PERSPECTA

News from every angle

← Back to headlines

Guardant Health Projects 27-30% Revenue Growth for 2026

Guardant Health anticipates 27-30% revenue growth for 2026, fueled by the expansion of its Shield and oncology portfolio.

20 Feb, 01:15 — 20 Feb, 01:15
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed193d ago

Guardant Health outlines 27%–30% revenue growth for 2026 while expanding Shield and oncology portfolio

Read full article →

Related Stories

Fed Chair Warsh Addresses Market Uncertainties Following Jackson Hole Symposium

48m ago

Global Government Bond Rout Drives Yields to Multi-Decade Highs

1h ago

Iran Claims Sufficient Foreign Reserves Despite US Sanctions

1h ago

European Inflation Hits Multi-Year Highs Driven by Energy Prices

1h ago